中国现代中药2019，Vol.21Issue(1)：1-19,19.DOI:10.13313/j.issn.1673-4890.20190102005
中药大品种科技竞争力报告(2018版)概要
Summary of Competitiveness Report on Science and Technology of Big Brand Traditional Chinese Medicine (2018 Edition)
摘要
Abstract
At present, the ecological pattern and operation rules of the pharmaceutical industry in China are changing dramatically, the traditional Chinese medicine industry is facing new challenges. The scientific and technological innovation driven by clinical and scientific value has become the main driving force for the high-quality development of Chinese medicine industry. Scientific and technological competitiveness embodies the clinical and scientific value of Chinese patent medicine products. Through the evaluation of scientific and technological competitiveness, it is helpful to form the correct value orientation, and promote the endogenous power of the industry. Based on the open data and evaluation model, the project team carried out the evaluation of the scientific and technological competitiveness of large varieties of traditional Chinese medicine, and compiled the "Report on the Scientific and Technological Competitiveness of Large Varieties of Traditional Chinese Medicine (2018 Edition) ", which panoramically displayed the general situation of the scientific and technological competitiveness of large varieties of traditional Chinese medicine. The top 100 list of the whole category, the top 100 list of non-injection, the top one of the provinces and regions, and the top three of the treatment fields are included in this article. Large varieties of traditional Chinese medicine (TCM) with the advantage of scientific and technological competitiveness are becoming the backbone force leading the high-quality development of TCM industry.关键词
中药大品种/科技竞争力/产品评价/大数据/评价模型/指标体系/科技因子Key words
big brand traditional Chinese medicine/scientific and technological competitiveness/scientific and technological evaluation/big data/evaluation model/evaluating indicator/scientific factor score分类
医药卫生引用本文复制引用
李耿,李振坤,郭宇博,程煜华,李文珊,刘立营,张秀梅,杨洪军..中药大品种科技竞争力报告(2018版)概要[J].中国现代中药,2019,21(1):1-19,19.基金项目
中国科协项目(2018-64) （2018-64）
国家中医药管理局项目(GZY-KJS-2018-016-09,GZY-FJS-2018-612) （GZY-KJS-2018-016-09,GZY-FJS-2018-612）
